Strategy
Futura Medical is seeking OTC medical device approval for ED treatment Eroxon Intense, designed for men who prefer a stronger sensation to the original Eroxon product.
“Four or five major acquisitions over the last few years repositioned it, a 140-year-old company, from being a B-to-B company to B-to B-to-C company. That is a major enterprise strategy shift,” says CEO Patrick Lockwood-Taylor.
“In a very siloed organization made up of a jigsaw of different companies, no one was thinking enterprise first,” says Perrigo CEO Patrick Lockwood-Taylor. “The fundamentals of running operations, brand-building, innovation, they are now as they were.”
Stada is reviewing potential M&A for its Consumer Healthcare business, which last year grew its sales despite a weak cough & cold season.
Haleon is making health literacy a core growth and sustainability pillar, aiming by 2030 to help more than 300m people a year take control of their everyday health through system‑level policy engagement, community programmes and improved access to self‑care products.
In a foreword to a blog post by PAGB CEO Michelle Riddalls, the UK medicines regulator MHRA has signalled strong support for expanding Rx‑to‑OTC reclassification as a safe way to ease pressure on the NHS, strengthen the role of pharmacists and improve access to medicines.
A new oral health manufacturing site in Shanghai will help facilitate Haleon's push into China's tier 2 and 3 cities where the middle class population is rapidly expanding.
A round-up of the latest European health & wellness people moves: Aboca hires Germany head; SkinBioTherapeutics gets interim CEO; Reckitt adds experience to board.
Avia Pharma has acquired fellow Swedish firm Allderma to add to its offering brands like Hårkontrol, Daxxin and Lactiplus.
Bayer Consumer Health will lean on its "road to billions" strategy to achieve growth in 2026 against a volatile market backdrop.
The global consumer health industry sees emerging markets as an engine for growth in an otherwise stagnating market. But panelists at the Global Self-Care Forum in Geneva warned that regulatory gaps and lack of harmonization may stunt this potential in the short term.
A round up of the latest health and wellness moves: Angelini Pharma names digital chief; SFI Health changes CEO; Nestlé adds experience to board.
In this episode of HBW Insight’s Over the Counter podcast, we speak with probiotic expert David Pineda Ereño about Europe’s fragmented regulatory landscape, the future of the “probiotic” definition, and how companies can navigate diverging EU Member State positions.
A round up of the latest health and wellness appointments: Stada names Eurasia region head; Galderma hires CFO; SkinBioTherapeutics announces investigation lead.
Moberg's success in Scandinavia gives the company the confidence that its upcoming expansion across Europe will be a success.
New data from Haleon shows that untreated tooth decay costs the UK £18.9bn, strengthening the case for a national focus on preventive oral care. The firm is also expanding its Sensodyne range to meet growing demand for products that combine whitening with sensitivity protection.
Sana Alajmovic is seeing strong interest from potential partners to launch virus-blocking mouth spray ColdZyme in new markets around the world.
A round-up of the latest European exec moves: Sanofi hires CEO from Merck; Lonza appoints to its board; SkinBioTherapeutics makes changes as CEO resigns.
Australian firm has received unsolicited approaches for its topical Pain Away brand and is considering its options.
Singapore's Zuellig Pharma picks up consumer health brands with over 100 years of heritage through deal with Bayer.